Casdin Capital 13F holdings, Q4 2021
Holdings as of December 31, 2021 · filings on SEC EDGAR · latest filing →
Casdin Capital disclosed 53 US equity positions worth $3.5bn in its Q4 2021 13F filing. The largest position was BLFS at 7.9% of the reported book, followed by EQRX INC and FATE. Against the Q3 2021 filing, it opened 4 new positions, added to 5 and reduced 12 among the top 50 holdings.
What did Casdin Capital own in Q4 2021? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2021 |
|---|---|---|---|---|---|---|---|
| 1 | BLFS BIOLIFE SOLUTIONS INC | Healthcare | 7.9% | $282.0m | 7,566,292 | 0% | held |
| 2 | EQRX INC | 7.6% | $269.6m | 39,527,669 | – | new | |
| 3 | FATE FATE THERAPEUTICS INC | Healthcare | 5.6% | $198.9m | 3,400,000 | 0% | held |
| 4 | INVITAE CORP | 5.3% | $186.3m | 12,203,669 | 0% | held | |
| 5 | ALNY ALNYLAM PHARMACEUTICALS INC | Healthcare | 4.8% | $169.6m | 1,000,000 | 0% | held |
| 6 | 2655787D BLUEPRINT MEDICINES CORP | 4.7% | $166.0m | 1,550,000 | 0% | held | |
| 7 | PACB PACIFIC BIOSCIENCES CALIF IN | Healthcare | 4.6% | $163.5m | 7,990,652 | 0% | held |
| 8 | EXK EXACT SCIENCES CORP | Basic Materials | 4.5% | $158.8m | 2,040,000 | -14% | reduced |
| 9 | SOMALOGIC INC | 4.1% | $144.2m | 12,389,082 | 0% | held | |
| 10 | MXCT MAXCYTE INC | 4.0% | $142.4m | 13,971,334 | 0% | held | |
| 11 | CDXS CODEXIS INC | Healthcare | 3.8% | $135.4m | 4,330,000 | 0% | held |
| 12 | SRPT SAREPTA THERAPEUTICS INC | Healthcare | 3.4% | $121.6m | 1,350,000 | 23% | added |
| 13 | RLAY RELAY THERAPEUTICS INC | Healthcare | 3.3% | $118.5m | 3,857,253 | 5% | added |
| 14 | VERVE THERAPEUTICS INC | 3.3% | $115.7m | 3,138,167 | 3% | added | |
| 15 | GH GUARDANT HEALTH INC | Healthcare | 2.2% | $79.0m | 790,000 | – | new |
| 16 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 1.9% | $68.7m | 2,090,000 | -3% | reduced |
| 17 | TNYA TENAYA THERAPEUTICS INC | 1.9% | $68.0m | 3,586,818 | 0% | held | |
| 18 | DNLI DENALI THERAPEUTICS INC | Healthcare | 1.9% | $66.9m | 1,500,000 | -12% | reduced |
| 19 | BEAM BEAM THERAPEUTICS INC | Healthcare | 1.8% | $65.3m | 818,820 | 0% | held |
| 20 | ABSI ABSCI CORPORATION | 1.8% | $63.3m | 7,718,593 | 0% | held | |
| 21 | TNGX TANGO THERAPEUTICS INC | Healthcare | 1.7% | $60.0m | 5,487,910 | 0% | held |
| 22 | RVMD REVOLUTION MEDICINES INC | Healthcare | 1.7% | $59.7m | 2,370,000 | -15% | reduced |
| 23 | CDNA CAREDX INC | Healthcare | 1.5% | $52.5m | 1,153,335 | -3% | reduced |
| 24 | TWST TWIST BIOSCIENCE CORP | Healthcare | 1.5% | $51.9m | 670,000 | -33% | reduced |
| 25 | IPSC CENTURY THERAPEUTICS INC | Healthcare | 1.4% | $50.9m | 3,206,380 | 0% | held |
| 26 | ONC BEIGENE LTD | Healthcare | 1.1% | $40.6m | 150,000 | 0% | held |
| 27 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 1.1% | $39.5m | 2,650,000 | 26% | added |
| 28 | GLOBAL BLOOD THERAPEUTICS IN | 1.1% | $38.8m | 1,325,000 | -31% | reduced | |
| 29 | GINKGO BIOWORKS HOLDINGS INC | 1.0% | $36.0m | 4,328,891 | -40% | reduced | |
| 30 | ALEC ALECTOR INC | Healthcare | 1.0% | $34.1m | 1,650,000 | 0% | held |
| 31 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 0.8% | $28.1m | 1,000,000 | -31% | reduced |
| 32 | DERMTECH INC | 0.8% | $27.6m | 1,745,000 | 0% | held | |
| 33 | SCIENCE 37 HOLDINGS INC | 0.6% | $22.4m | 1,800,000 | – | new | |
| 34 | WGS SEMA4 HOLDINGS CORP | 0.6% | $22.3m | 5,000,000 | 0% | held | |
| 35 | CRSP CRISPR THERAPEUTICS AG | Healthcare | 0.6% | $20.2m | 266,430 | 0% | held |
| 36 | GLUE MONTE ROSA THERAPEUTICS INC | 0.6% | $19.6m | 960,882 | -0% | held | |
| 37 | SEER SEER INC | 0.5% | $18.2m | 800,000 | 433% | added | |
| 38 | MAGENTA THERAPEUTICS INC | 0.5% | $17.3m | 3,901,589 | 0% | held | |
| 39 | SINGULAR GENOMICS SYSTEMS IN | 0.5% | $16.7m | 1,442,870 | -46% | reduced | |
| 40 | EXSCIENTIA PLC | 0.4% | $14.1m | 713,900 | – | new | |
| 41 | 23ANDME HOLDING CO | 0.3% | $12.3m | 1,841,457 | 0% | held | |
| 42 | 4D MOLECULAR THERAPEUTICS IN | 0.3% | $12.2m | 555,455 | -50% | reduced | |
| 43 | MASS 908 DEVICES INC | 0.3% | $10.5m | 406,502 | 0% | held | |
| 44 | ZLAB ZAI LAB LTD | Healthcare | 0.3% | $9.4m | 150,000 | -21% | reduced |
| 45 | RXRX RECURSION PHARMACEUTICALS IN | Healthcare | 0.3% | $9.4m | 548,156 | 0% | held |
| 46 | GENERATION BIO CO | 0.3% | $9.4m | 1,324,275 | 0% | held | |
| 47 | ORIC ORIC PHARMACEUTICALS INC | Healthcare | 0.2% | $8.8m | 601,515 | 0% | held |
| 48 | KRONOS BIO INC | 0.2% | $7.9m | 583,436 | 0% | held | |
| 49 | DECIBEL THERAPEUTICS INC | 0.2% | $5.4m | 1,170,048 | 0% | held | |
| 50 | BERKELEY LTS INC | 0.1% | $3.6m | 200,000 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.